Plasmapheresis in controlling of the severity of ischemia-reperfusion damage of renal transplant


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim. Estimation of role of plasmapheresis in protection of renal transplant function. Methods. 80 renal transplant recipients were included into the study. In 40 of the plasmapheresis was perfomed during 1st 24 hours of transplant repefusion; 40 patients did not undergo plasmapheresis. Immusupressive therapy was equal in both groups. Renal transplant function was estimated according to serum creatinine level, glomerular filtration rate (GFR), and hemodyalisis requirement after renal transplantation. Results. Plasmapheresis, performed during 1st 24 hours after start of renal transplant reperfusion, lead to more prominent elevation of GFR and decrease in serum creatinine concentration. Number of patients, who required hemodyalisis after renal transplantation, was more than 5 times less in plasmapheresis group. Conclusion. Plasmapheresis can be used for protection of renal transplant ischemia-reperfusion damage.

全文:

受限制的访问

参考

  1. Bronzatto E.J., da Silva Quadros K.R., Santos R.L. et al. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis. Transplant Proc. 2009; 41(3): 849-851.
  2. Yarlagadda S.G., Coca S.G., Formica R.N. Jr. et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009; 24(3): 1039-1047.
  3. Grosso G., Corona D., Mistretta A. et al. Delayed graft function and long-term outcome in kidney transplantation. Transplant Proc. 2012; 44(7): 1879-1883.
  4. Eltzschig H.K., Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med. 2011; 17(11): 1391-1401.
  5. Siedlecki A., Irish W., Brennan D.C. Delayed graft function in the kidney transplant. Am J Transplant. 2011; 11(11): 2279-2296.
  6. Girn H.R., Ahilathirunayagam S., Mavor A.I. et al. Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg. 2007; 41(4): 277-293.
  7. Kosieradzki M., Rowinski W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 2008; 40(10): 3279-3288.
  8. Cicora F., Roberti J., Lausada N. et al. Donor preconditioning with rabbit anti-rat thymocyte immunoglobulin ameliorates ischemia reperfusion injury in rat kidney transplantation. Transpl Immunol. 2012; 27(1): 1-7.
  9. Cicora F., Roberti J., Vasquez D. et al. Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. Clin Exp Immunol. 2012; 167(1): 169-177.
  10. Chatterjee P.K. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2007; 376(1-2): 1-43.
  11. Thuillier R., Renard C., Rogel-Gaillard C. et al. Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation. Br J Surg. 2011; 98(3): 368-378.
  12. Zaouali M.A., Ben Abdennebi H., Padrissa-Altés S. et al. Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother. 2010; 11(4): 537-555.
  13. Lam V.W., Laurence J.M., Richardson A.J. et al. Hypothermic machine perfusion in deceased donor kidney transplantation: a systematic review. J Surg Res. 2013; 180(1): 176-182.
  14. Hosgood S.A., Nicholson H.F., Nicholson M.L. Oxygenated kidney preservation techniques. Transplantation. 2012; 93(5): 455-459.
  15. Беляев А.Ю., Мойсюк Я.Г., Ильинский И.М. и др. К вопросу об этиологии и патогенезе первично нефункционирующего трансплантата почки // Вестник трансплантологии и искусственных органов. 2000; (2): 4-7.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##